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Introduction
Pleomorphic adenoma (PA) is the most com-
mon benign tumor of salivary glands. The tumor 
can also be classified as a mixed tumor due to 
its epithelial and mesenchymal components. In 
all, 80% of PAs occur in the parotid, 10% in the 
submandibular gland, and 10% in the minor sal-
ivary and sublingual glands. PAs of the subman-
dibular gland are more common among women 
between 40 and 60 years of age. They usually 
present in the submandibular area as a painless 
hard mass. Histologically, PA is encapsulated 
by a thin capsule that forms around the salivary 
gland parenchyma due to fibrosis secondary to 
mass effect, which is also known as a pseudocap-
sule. The standard treatment for these tumors is 
surgical excision (1, 2). In recurring PA, there 
have been different hypotheses put forth based 
on histopathological and genetic factors. These 
are pseudopods in the capsule, incomplete cap-
sule, satellite nodules, early development, stro-
ma-rich variant, insufficient surgical procedure, 
and tumor implantation during surgical proce-
dure (3-6). In this case report, we aim to discuss 
the reasons of rare submandibular gland PA re-
currence and methods to prevent recurrence. 
Case
A 32-year-old female patient presented with a 
painless swelling in her right submandibular region. 
She had been operated in another hospital 5 years 
earlier for the same complaint. Histopathological 
examination of the excised right submandibular 
gland revealed PA. Ultrasonography (US) of the 
neck revealed multiple 12x9 mm solid hypoechoic 
lesions with defined contours at the previous re-
section site. These lesions were hypovascular, but 
had heterogeneous perfusion patterns. Elasto-
graphic analysis showed lesions with mid-solidity 
(strain ratio: 1.25–2.25). Neck magnetic resonance 
imaging (MRI) showed an approximately 40x22 
mm lesion with multiple solid nodular lesions 
localized at the submandibular gland, the larg-
est being 12x10 mm, which was enhanced by the 
contrast agent. These images resembled a “potato 
sack” (Figure 1,2). These nodules were hypointense 
with T1A and hyperintense with T2A enhanced 
analysis. Fine needle aspiration biopsy (FNAB) 
was performed and cytopathological examination 
confirmed PA. 
The patient underwent mass excision and neck 
dissection at levels 1, 2a, 2b, and 3. A well-defined 
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5-cm mass with solid features was identified at level 2a. In ad-
dition, a mass was dissected at the digastric muscle level while 
preserving the hypoglossal nerve. Marginal mandibular branch 
of the facial nerve was paralytic prior to operation, and during 
the operation, marginal branch of the facial nerve was not ob-
served. Histopathological examination revealed that the multi-
ple tan-white nodular tissue fragments with attached adipose 
tissue (ranging from 0.2 cm to 1.5 cm) were PAs (Figure 3, 4). 
In addition, 12 reactive lymph nodes were identified. The patient 
was asymptomatic and residual tumor tissue or recurrence was 
not observed at the 1-year follow-up.
Discussion
Salivary gland tumors constitute 3%-4% of the head and neck 
cancers, of which, 8%-22% are seen in the submandibular gland. 
Approximately 50%-57% of neoplasms in the submandibular 
gland are benign and mostly PAs. Of the malignant tumors, ad-
enoid cystic carcinoma is the most common. PAs, also known 
as benign mixed tumors, are the most common benign salivary 
gland tumors. They are classified as mixed tumors due to the 
epithelial and mesenchymal components of the neoplasm (1). 
Ectopic PAs can be observed in the paranasal sinuses, pharynx, 
larynx, and bronchi (2). 
It is difficult to distinguish between benign and malignant neo-
plasms based on the clinical symptoms and radiologic exam-
ination (1). Pain due to benign tumor is reported in 2%–20% 
cases. The role of FNAB in diagnosis is controversial. Although 
FNAB is reliable in distinguishing between benign and malig-
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Figure 1. T2 axial MR images of tumor in the right submandibular 
area resembling a potato sack
Figure 2. T2 coronal MR images of tumor in the right submandibular 
area resembling a potato sack
Figure 3. (H&E ×100) Recurrent pleomorphic adenoma within 
adipose tissue demonstrating nodular development
Figure 4. (H&E ×200) Tumor with chondromyxoid stroma and 
myoepithelial cellular areas. Focal ductal differentiation is observed
nant lesions, it does not provide accurate diagnosis as compared 
with definitive histopathological examination (7). In a study of 
25 submandibular neoplasms by Ethunandan et al., FNAB ac-
curately identified 78% benign tumors but no malignant tumors 
(7). FNAB before the surgery can be useful from a medicolegal 
perspective despite the perplexing importance of FNAB in sal-
ivary glands.
The decline in recurrent PA incidence may be due to the re-
placement of enucleation in parotid tumors with superficial lo-
bectomies and total parotidectomies. Minor salivary gland and 
submandibular gland tumors are treated by total gland excision. 
For recurrent PA, there are several hypotheses based on histo-
pathological and genetic factors as mentioned above. In a differ-
ent series, the incidence of recurrence of parotid PA following 
the primary surgery was shown to be between 0.8% and 5%. Re-
currence is common after surgery for recurrent adenomas (3-6). 
Recurrences most often present with multilocular development 
and complete surgical excision is difficult.
Oudidi et al. (8) performed total gland excision without any 
recurrence. Roh and Park (9) evaluated 20 patients with PA, 
who were treated only with tumor extirpation, and found no 
recurrence at a median of 36 months after surgery. In con-
trast, Munir and Bradley (11) diagnosed 32 patients with PA 
in a 16-year period and performed extracapsullary excision on 
13 of them and additional level 1b, 2a, and 3 neck dissections 
on 19 of them. There was no recurrence in these patients in 
their mean 10-month follow-up. They also identified 5 cases of 
patients with PA who were previously treated elsewhere. The 
patients with recurrent PA had previously undergone extra-
capsular submandibular gland excision at a different hospital. 
The recurrence time after initial surgery for these patients var-
ied between 5 and 30 years. Three of these patients had multi-
focal, one had nodular, and one had two nodular recurrences. 
In the case presented herein, the recurrence was detected after 
5 years and the multinodular lesions had a potato sack-like 
appearance on MR images. Ziglinas et al. (12) identified 41 
submandibular gland tumor cases, of which 20 were benign 
and 21 were malignant. Of the 20 benign tumors, 17 were PAs. 
No recurrence was seen in more than 5-year follow-up. On the 
other hand, Alves et al. (13) identified 54 recent submandib-
ular gland PA cases and found one case of recurrence at the 
3-year follow-up. They treated four cases of recurrent PA. In 
two of them, both the submandibular gland and the tumor 
were excised. In the other two, only the tumor was resected be-
cause the gland had been removed previously. They also report-
ed that although capsule invasion does not indicate malignant 
transformation, it may be a reason for recurrence. We decided 
to perform level 1-2-3 neck dissection considering the multi-
nodular structure of the mass and to ensure complete excision. 
Marginal mandibular branch paralysis of the facial nerve was 
observed after the first operation; therefore, we assume that 
complete tumor excision or retention of the submandibular 
gland capsule integrity was difficult.
Conclusion
Although several cases of recurrent parotid gland PA have been 
reported in the literature, recurrent submandibular gland PA is 
quite rare. There are different hypotheses for the reason of re-
currence. Complete surgical removal of tumor of the subman-
dibular gland and keeping the capsule intact during surgery are 
important to prevent recurrence.
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